Aug 11, 2022 / 10:00PM GMT
Liza Garcia - UBS - Analyst
Welcome back. You've got me again -- Liza Garcia, UBS life science tools and diagnostics analyst. I'm joined here by my co-coverage, John Sourbeer, and we are fortunate enough to be here with Quantum-Si. We've got Patrick Schneider, the President and Chief Operations Officer of the company with us. So welcome. I'm excited to have a conversation.
All right. So let's talk about the story here and maybe dig into what Quantum-Si is about and get investors comfortable -- or more familiar with the story.
Questions and Answers:
Liza Garcia - UBS - AnalystSo the real-time single-molecule protein direct sequencing platform -- can you talk us through the technological innovations that allow for the scale that you can currently achieve?
Patrick Schneider - Quantum-Si Incorporated - President & COO
Yeah. And thank you for the invitation, and thank you all for your interest in Quantum-Si.
So specifically talking about the technology, there are several different aspects of